These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16246451)

  • 1. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ
    J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of cirrhosis.
    Mendez C; Marsano L; Wright R
    J Ky Med Assoc; 2003 Sep; 101(9):403-14. PubMed ID: 14556436
    [No Abstract]   [Full Text] [Related]  

  • 5. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIPS for management of refractory ascites: response and survival are both unpredictable.
    Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
    Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.
    Farsad K; Kolbeck KJ; Keller FS; Barton RE; Kaufman JA
    AJR Am J Roentgenol; 2015 Apr; 204(4):868-71. PubMed ID: 25794080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS versus paracentesis for the treatment of refractory ascites.
    Lau A; Bay C; Nadir A
    Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension complications].
    Xu K; Han GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):481-2. PubMed ID: 22152232
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
    Dasarathy J; Alkhouri N; Dasarathy S
    Liver Int; 2011 Oct; 31(9):1250-8. PubMed ID: 21745273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of the refractory ascites: Total paracentesis vs. TIPS.
    La Mura V; Salerno F
    Gastroenterol Hepatol; 2016; 39(7):477-80. PubMed ID: 26596208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic hydrothorax.
    Strauss RM; Boyer TD
    Semin Liver Dis; 1997; 17(3):227-32. PubMed ID: 9308127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.
    Allard JP; Chau J; Sandokji K; Blendis LM; Wong F
    Am J Gastroenterol; 2001 Aug; 96(8):2442-7. PubMed ID: 11513188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the diagnosis and treatment of hepatic hydrothorax].
    Li HC; Li X; Tang CW
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):958-60. PubMed ID: 20038347
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 18. Portal hypertension.
    Garcia-Tsao G
    Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 20. Transjugular intrahepatic porto-systemic shunt to relieve refractory ascites in a patient with cirrhosis and portal hypertension.
    Joseph G; George OK; Jayanthi V
    Indian Heart J; 2002; 54(6):731-2. PubMed ID: 12674194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.